Skip to content

NIKA PHARMACEUTICALS, INC

NIKA

CIK 0001145604

← back to feed
Revenue (TTM)
$0
Q1 Apr 2026
Net Income (TTM)
−$52.68K
+20.2% YoY Q1 Apr 2026
EPS Diluted (TTM)
$0.00
Q1 Apr 2026
Gross Margin
—
Q1 Apr 2026
Operating Margin
—
Q1 Apr 2026
Net Margin
—
Q1 Apr 2026
Free Cash Flow (TTM)
—
Q1 Apr 2026
Cash
$1.53K
Q1 Apr 2026
Total Debt
$331.62K
Q1 Apr 2026
Shares Outstanding
1.05B sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings